These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 27311820

  • 1. Melanin and neuromelanin binding of drugs and chemicals: toxicological implications.
    Karlsson O, Lindquist NG.
    Arch Toxicol; 2016 Aug; 90(8):1883-91. PubMed ID: 27311820
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.
    Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MB.
    J Neurochem; 1992 Sep; 59(3):1168-71. PubMed ID: 1494904
    [Abstract] [Full Text] [Related]

  • 9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 10. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
    Krainc T, Monje MHG, Kinsinger M, Bustos BI, Lubbe SJ.
    Mov Disord; 2023 Feb; 38(2):185-195. PubMed ID: 36350228
    [Abstract] [Full Text] [Related]

  • 11. Neuromelanin and its possible protective and destructive properties.
    Lindquist NG, Larsson BS, Lydén-Sokolowski A.
    Pigment Cell Res; 1987 Feb; 1(3):133-6. PubMed ID: 3334086
    [Abstract] [Full Text] [Related]

  • 12. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis.
    Enochs WS, Sarna T, Zecca L, Riley PA, Swartz HM.
    J Neural Transm Park Dis Dement Sect; 1994 Feb; 7(2):83-100. PubMed ID: 7710667
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: characterization by electron paramagnetic resonance spectroscopy.
    Enochs WS, Nilges MJ, Swartz HM.
    J Neurochem; 1993 Jul; 61(1):68-79. PubMed ID: 8390568
    [Abstract] [Full Text] [Related]

  • 15. Interaction between chemicals and melanin.
    Larsson BS.
    Pigment Cell Res; 1993 Jun; 6(3):127-33. PubMed ID: 8234197
    [Abstract] [Full Text] [Related]

  • 16. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R.
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [Abstract] [Full Text] [Related]

  • 17. Preclinical signs of Parkinson's disease: A possible association of Parkinson's disease with skin and hair features.
    Jucevičiūtė N, Banaitytė I, Vaitkus A, Balnytė R.
    Med Hypotheses; 2019 Jun; 127():100-104. PubMed ID: 31088630
    [Abstract] [Full Text] [Related]

  • 18. Iron, melanin and dopamine interaction: relevance to Parkinson's disease.
    Ben-Shachar D, Youdim MB.
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):139-50. PubMed ID: 8416600
    [Abstract] [Full Text] [Related]

  • 19. Functional effects of neuromelanin and synthetic melanin in model systems.
    Double KL.
    J Neural Transm (Vienna); 2006 Jun; 113(6):751-6. PubMed ID: 16755379
    [Abstract] [Full Text] [Related]

  • 20. Melanin and Neuromelanin Fluorescence Studies Focusing on Parkinson's Disease and Its Inherent Risk for Melanoma.
    Leupold D, Szyc L, Stankovic G, Strobel S, Völker HU, Fleck U, Müller T, Scholz M, Riederer P, Monoranu CM.
    Cells; 2019 Jun 15; 8(6):. PubMed ID: 31208049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.